Details for New Drug Application (NDA): 017386
✉ Email this page to a colleague
The generic ingredient in ZAROXOLYN is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Summary for 017386
Tradename: | ZAROXOLYN |
Applicant: | I3 Pharms |
Ingredient: | metolazone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017386
Suppliers and Packaging for NDA: 017386
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZAROXOLYN | metolazone | TABLET;ORAL | 017386 | NDA AUTHORIZED GENERIC | Aphena Pharma Solutions - Tennessee, LLC | 43353-999 | 43353-999-09 | 9000 TABLET in 1 BOTTLE, PLASTIC (43353-999-09) |
ZAROXOLYN | metolazone | TABLET;ORAL | 017386 | NDA AUTHORIZED GENERIC | Aphena Pharma Solutions - Tennessee, LLC | 71610-142 | 71610-142-09 | 9000 TABLET in 1 BOTTLE, PLASTIC (71610-142-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription